Genomic characterization of HNSCC has recently been reported, and amplification of receptor tyrosine kinases, including EGFR and ERBB2, was commonly identified in HPV‐negative HNSCC.12 The gene discussed is ERBB2; the disease is head and neck squamous cell carcinoma.